With more and more frequency, nanotechnology is being offered to the American public as a transformative technology, with the potential to improve every aspect of our social, physical, and economic well-being.
As a r...
Agilent Technologies Inc. today introduced a new Dynamic Calibrator, a laser-based calibration system for measuring machine-tool and coordinate-measuring-machine (CMM) accuracy. New sensors in the system offer accuracy to 0.4ppm, setting a new industry standard.
Harvard University and Diagnostics-For-All, Inc., (DFA) have entered into an agreement aimed at developing a new generation of portable, low-cost, user-friendly diagnostic solutions and make this technology accessible to...
Arrowhead Research Corporation announced today that Unidym, Inc., its majority-owned subsidiary, has received a $2.0 million strategic investment from Entegris, Inc., a leading provider of products for purifying, protect...
Selah Technologies, an advanced materials manufacturer, announced today that it has received a patent covering the carbon single wall nanotube enrichment process to produce Selah Tubes(TM). Selah has the worldwide exclusive license for US Patent No. 7,374,685 from Clemson University.
Innovative solutions to the problem of storing energy generated by renewable sources are being developed by researchers at The University of Nottingham.
MMFX Technologies Corporation, an Irvine-based materials science company that, among other things, uses nanotechnology to manufacture high-strength, corrosion-resistant steel, has received a $55 million commitment in sec...
Higher Education Minister Dr. Khaled Al-Anqari yesterday commended King Abdullah's moral and material support to research centers on nanotechnology and its applications in the Kingdom.
Opening an international co...
Coinciding with the BIO International Convention held in San Diego CA, NanoInterventions introduces the "Mouse Stent Model" for rapid screening of new coronary stent therapeutics. The model, complete with a mini-stent of spectacularly small size and its ability to replicate the human diseased vessel, represents a new starting point in the development of next-generation drug-eluting coronary stents.
Carbon Nanoprobes, Inc. (CN Probes) and First Nano have signed an agreement that enables CN Probes to finish development of their high-tech nano imaging platform.
CN Probes has selected First Nano's Applications ...
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.